How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/renal-osteodystrophy-with-hyperphosphatemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Renal Osteodystrophy with Hyperphosphatemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Renal Osteodystrophy with Hyperphosphatemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Renal Osteodystrophy with Hyperphosphatemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Renvela	SEVELAMER CARBONATE	Sanofi	Phosphate Binder	2007-01-01
Phoslo	CALCIUM ACETATE	Fresenius Medcl Care	calcium acetate	1982-01-01
Renvela	Renvela	Ardelyx

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Ardelyx · 1 drug in Renal Osteodystrophy with Hyperphosphatemia
Fresenius Medcl Care · 1 drug in Renal Osteodystrophy with Hyperphosphatemia
Sanofi · 1 drug in Renal Osteodystrophy with Hyperphosphatemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Renal Osteodystrophy with Hyperphosphatemia:

Cite this brief

Drug Landscape (2026). Renal Osteodystrophy with Hyperphosphatemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/renal-osteodystrophy-with-hyperphosphatemia. Accessed 2026-06-10.

Renal Osteodystrophy with Hyperphosphatemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing